Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: oral nucleoside analogues - Pharmasset

Next Previous
Drug Profile

Research programme: oral nucleoside analogues - Pharmasset

Alternative Names: Nucleos(t)ide analogue polymerase inhibitors - Pharmasset; PSI-352666; PSI-352879; PSI-353661; PSI-6206; PSI-6206 monophosphate; PSI-6206 phosphate; PSI-6206 triphosphate; PSI-661; PSI-879

Latest Information Update: 02 Feb 2012

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pharmasset
  • Class Nucleosides; Nucleotides; Purine nucleotides; Pyrimidine nucleotides; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Hepatitis C; HIV infections

Most Recent Events

  • 02 Feb 2012 No development reported - Preclinical for Hepatitis C in USA (PO)
  • 02 Feb 2012 No development reported for HIV infections in USA (PO)
  • 17 Jan 2012 Pharmasset has been acquired by Gilead Sciences

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top